Mylan Inc. has launched risedronate sodium tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel tablets. Mylan received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... PharmaBiz, 1 month ago
Mylan releases generic Actonel - Chain Drug Review, 1 month ago
Mylan Launches Generic Actonel® Tablets, 150 mg - SearchBug, 1 month ago
2 images for "warner chilcott"
Brand manufacturer Mayne Pharma and the U.S. marketer of Mayne's acne drug Doryx, Warner Chilcott, have moved to settle class action claims with third party purchasers that allege the two companies inappropriately delayed generic competition on the ...FDA News, 2 days ago
Foamix Establishes U.S. Subsidiary and Strengthens Executive Management With Appointment of Senior U.S. Leadership Team
New Senior Managers and Advisors Were Previously at Warner-Chilcott Inc., Overseeing Revenue Growth from $117 Million in 2001 to More Than $2.7 Billion in 2011. Team Brings Expertise in Sales, Marketing, Operations, Clinical Development, ...Virtual Strategy Magazine, 1 month ago Salix, Cosmo See Green in $2.7B Merger Genetic Engineering News, 2 weeks ago HBM Healthcare Investments : Paratek Pharmaceuticals signs merger agreement with NASDAQ-listed Transcept Pharmaceuticals 4 Traders, 3 weeks ago Bay Area's Transcept Pharmaceuticals, Inc. Soars On Plans To Merge With Paratek Pharmaceuticals, Inc., Picks Up $93 Million Along The Way; Stock Up +19.60% At Market Close (July 1, 2014) BioSpace, 3 weeks ago
New Market Report Now Available: Warner Chilcott Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
New Consumer Goods market report from MarketLine: "" Boston, MA -- (SBWIRE) -- 06/24/2014 -- MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and ...Digital Journal, 1 month ago
(SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Warner Chilcott (NASDAQ:WCRX) on January 17th, 2013 at $13.53. In approximately 17 months, Warner Chilcott has returned 69.54% as of today's recent price of $22.93. Over ...TradingCharts.com, 1 month ago Uptrend Call Working As Warner Chilcott Stock Rises 69.5% (WCRX) Comtex SmarTrend, 1 month ago
US-based pharmaceutical firm Mylan has launched Risedronate Sodium Tablets USP, 150mg, the generic version of Warner Chilcott's Actonel Tablets. The company secured final approval from the US Food and Drug Administration (FDA) for its abbreviated ...Pharmaceutical Business Review, 1 month ago
Cadila Healthcare and Zydus Pharmaceuticals of Ahmedabad have finalised an agreement with Warner Chilcott of USA to settle patent litigation related to Asacol. As per the agreement, Zydus will get a royalty bearing licence to sell a ...Pharmacy Choice, 1 month ago
In a corporate inversion, a U.S. corporation — typically the parent of an affiliated group — becomes a wholly owned subsidiary of a foreign corporation through a merger into the foreign corporation's U.S. subsidiary or transfers its assets to ...JD Supra, 14 hours ago Corporate inversions showing no signs of slowing down Lexology, 1 month ago
If their advisor tells them their portfolio is up say 7% this year, they'll come back with something like "Yeah, but if such-and-such investment hadn't tanked, I'd be up 10%." Because the pain of losses tends to outweigh the thrill of gains, I ...Yahoo! Finance, 17 hours ago
Summary Valeant complained to the SEC about Allergan's "misstatements" on B&L organic growth. The SEC should take this opportunity to examine Valeant's earnings releases and ask the following from Valeant. Clearly report the negative organic ...Seeking Alpha, 3 days ago
on your WebpageAdd Widget >Get your members hooked!